Anzeige
Mehr »
Montag, 27.10.2025 - Börsentäglich über 12.000 News
Automatisierung ist das neue Gold: Telescope Innovations erfindet Entdeckung von Medizin & Materialien neu!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DJR2 | ISIN: SE0009268717 | Ticker-Symbol: 7AC
Frankfurt
27.10.25 | 08:03
0,018 Euro
-22,98 % -0,005
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ACARIX AB Chart 1 Jahr
5-Tage-Chart
ACARIX AB 5-Tage-Chart

Aktuelle News zur ACARIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:35Acarix AB: Announcement from the general meeting in Acarix AB59The extraordinary general meeting 2025 (the "EGM") of Acarix AB ("Acarix" or the "Company") was held today on 27 October 2025 and the following resolutions were passed unanimously by the meeting. Change...
► Artikel lesen
17.10.Acarix AB: Acarix responds to G-BA decision on reimbursement in the German market138Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that G-BA reached a negative decision on the possibility for CADScor System to receive reimbursement...
► Artikel lesen
ACARIX Aktie jetzt für 0€ handeln
21.08.Acarix AB: Acarix Reports Significant Progress Toward Fixed Reimbursement159Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that the company has achieved another milestone on its path toward fixed reimbursement...
► Artikel lesen
21.08.Acarix AB: Acarix Publishes Interim Report, January - June 2025139Malmö, Sweden (Aug. 21, 2025) - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the second quarter and first half of 2025. The...
► Artikel lesen
28.07.Acarix AB: Acarix achieves new Fixed U.S. reimbursement milestone for CADScor at $300.00 USD221Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that a second payer has agreed to provide fixed reimbursement of $300 for the CADScor®...
► Artikel lesen
08.07.Acarix AB: Acarix Enters MENA Region with First Major Order, Expanding Global Presence251Malmö, Sweden - July 8, 2025 - Acarix, a global pioneer in AI-driven and acoustics-based cardiac diagnostics, is proud to announce its first order in the Middle East and North Africa (MENA) region....
► Artikel lesen
26.06.Acarix AB: Acarix Applauds New Peer-Reviewed Study Demonstrating Cost-Effectiveness of the CADScor System in U.S. Emergency Departments241Malmö, Sweden - Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics - Open demonstrating that the CADScor®...
► Artikel lesen
16.06.Acarix AB: Acarix Achieves First Fixed U.S. Reimbursement Milestone for CADScor at $300.00 USD228Malmö, Sweden - Acarix a global leader in AI and acoustics-based cardiac diagnostics, is pleased to announce that the first payor has agreed to provide fixed reimbursement for the CADScor® System at...
► Artikel lesen
12.05.Acarix AB: Acarix Publishes Interim Report, January - March 2025326Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the first quarter of 2025. The report highlights continued growth in the U.S....
► Artikel lesen
13.02.Acarix Publishes Year-End Report 2024 - Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts349OKLAHOMA CITY, Feb. 13, 2025 /PRNewswire/ -- Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues...
► Artikel lesen
07.11.24Acarix AB: Acarix Publishes Third Quarter 2024 Report237Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 2024. The company has made significant progress toward operational...
► Artikel lesen
11 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1